Corrigendum to "Generation of a set of isogenic, gene-edited iPSC lines homozygous for all main APOE variants and an APOE knock-out line" [Stem Cell Res. 34/1873-5061 (2019) 101349-55]
1 Bioneer A/S, Kogle Alle 2, 2970 Hørsholm, Denmark.
2 Bioneer A/S, Kogle Alle 2, 2970 Hørsholm, Denmark; Department of Clinical Microscopy, Faculty of Medical Technology, Mahidol University, Bangkok 10700, Thailand.
3 Neurometabolism Research Unit, Department of Drug Design and Pharmacology, University of Copenhagen, Denmark.
4 Institute of Medical Genetics and Applied Genomics, Division of Cytogenetics, Calwerstrasse 7, University of Tuebingen, 72076, Germany.
5 Institute for Stem Cell Biology and Regenerative Medicine (inStem), Bengaluru, Karnataka, India; University of Trans-Disciplinary Health Sciences & Technology (TDU), Bengaluru, Karnataka, India.
6 Institute for Stem Cell Biology and Regenerative Medicine (inStem), Bengaluru, Karnataka, India.
7 Censo Biotechnologies, Edinburgh EH25 9PP, UK.
8 Janssen Research & Development, a division of Janssen Pharmaceutica; N.V., Neuroscience Therapeutic Area, Turnhoutseweg 30, 2340 Beerse, Belgium.
9 Janssen Research & Development, a division of Janssen Pharmaceutica; N.V., Neuroscience Therapeutic Area, Turnhoutseweg 30, 2340 Beerse, Belgium. Electronic address: acabrer8@its.jnj.com.